Eli Lilly and Company's Mounjaro KwikPen drug for type 2 diabetes and obesity is a multi-dose, prescription-based, single-patient-use prefilled pen which has been designed for once a week administration. Each pen will deliver four fixed doses of 0.6 mL and has been approved in six dosage strengths for the Indian market: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg.